pargyline has been researched along with quercetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, CF; Chan, KF; Chan, TH; Chong, TC; Chow, LMC; Chow, TS; Cui, J; Law, MC; Liu, Z; Wong, ILK; Zhu, X | 1 |
| Carpéné, C; Marti, L; Prévot, D; Visentin, V | 1 |
2 other study(ies) available for pargyline and quercetin
| Article | Year |
|---|---|
Flavonoid Monomers as Potent, Nontoxic, and Selective Modulators of the Breast Cancer Resistance Protein (ABCG2).
Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavonoids; HEK293 Cells; Humans; Mitoxantrone; Neoplasm Proteins; Structure-Activity Relationship; Substrate Specificity | 2021 |
Inhibition of rat fat cell lipolysis by monoamine oxidase and semicarbazide-sensitive amine oxidase substrates.
Topics: Adipocytes; Amine Oxidase (Copper-Containing); Androstadienes; Animals; Benzylamines; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Glutathione; Hydrogen Peroxide; Insulin; Isoproterenol; Lipolysis; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxidation-Reduction; Pargyline; Phosphoinositide-3 Kinase Inhibitors; Quercetin; Rats; Rats, Wistar; Substrate Specificity; Tyramine; Vanadates; Wortmannin | 2003 |